Meeting
2021 ASCO Annual Meeting
Immunity to childhood vaccines following high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) for germ cell tumors (GCT) with comparison to Hodgkin lymphoma (HL).
Authors
Darren R. Feldman
Memorial Sloan Kettering Cancer Center, New York, NY
Darren R. Feldman , Akeem Ronell Lewis , Andrea Knezevic , David Ali , Maria Bromberg , Julia Aronson , Samuel Aaron Funt , Deaglan Joseph McHugh , Robert J. Motzer , Dean F. Bajorin , Sujata Patil , Gunjan L. Shah , Monika Shah , Susan Seo , Mini Kamboj , Miguel-Angel Perales , Genofeva Papanicolaou
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Germ Cell/Testicular Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5017)
DOI
10.1200/JCO.2021.39.15_suppl.5017
Abstract #
5017
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
High doses of chemotherapy and autologous hematopoietic stem cell transplantation in patients with relapsed/refractory testicular germ cell tumors: Multicenter real-world experience in Argentina.
First Author: Federico Losco
Poster
2023 ASCO Annual Meeting
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs).
First Author: Danka Sinikovic Zebic
Poster
2023 ASCO Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate- and poor-risk metastatic germ cell tumours (GCTs).
First Author: Danka Zebic
Poster
2023 ASCO Genitourinary Cancers Symposium
High-dose chemotherapy with autologous stem cell transplant (HDCT) for patients (pts) with advanced germ-cell tumors (aGCT): Real-world evidence from a tertiary cancer center in Brazil.
First Author: Gabriel Berlingieri Polho